| 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 医疗(元) | 99,604,429.94 | 38,126,584.75 | 82,509,485.94 | 48,556,163.02 |
| 医药收入(元) | 109,750,608.90 | 63,189,607.97 | 126,362,527.30 | 49,235,669.53 |
| 营业成本(元) | ||||
| 医疗(元) | 77,066,868.57 | 34,622,109.14 | 67,255,625.37 | 44,736,548.99 |
| 医药收入(元) | 94,682,143.36 | 57,650,998.79 | 107,710,742.79 | 45,237,385.68 |
| 毛利(元) | ||||
| 医疗(元) | 22,537,561.37 | 3,504,475.61 | 15,253,860.57 | 3,819,614.03 |
| 医药收入(元) | 15,068,465.54 | 5,538,609.18 | 18,651,784.51 | 3,998,283.85 |
| 毛利率(%) | ||||
| 医疗(%) | 22.63 | 9.19 | 18.49 | 7.87 |
| 医药收入(%) | 13.73 | 8.77 | 14.76 | 8.12 |
| 收入构成(%) | ||||
| 医疗(%) | 47.58 | 37.63 | 39.50 | 49.65 |
| 医药收入(%) | 52.42 | 62.37 | 60.50 | 50.35 |
| 毛利构成(%) | ||||
| 医疗(%) | 59.93 | 38.75 | 44.99 | 48.86 |
| 医药收入(%) | 40.07 | 61.25 | 55.01 | 51.14 |